OLIVIA GIFFORD: Open Payments
NPI 1235843780 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 44 payments from 14 companies in 2025. Trend: 2023 $372 · 2024 $539 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $184 |
| Novo Nordisk Inc | 7 | $120 |
| Lilly USA, LLC | 8 | $101 |
| Astellas Pharma US Inc | 3 | $58 |
| SANOFI-AVENTIS U.S. LLC | 2 | $31 |
| Exact Sciences Corporation | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: PREVNAR 20, MOUNJARO, Veozah, Wegovy, Ozempic, TZIELD, ELIQUIS, NURTEC ODT.
Industry payments across NE — which companies pay providers there.
